CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 68911-69051
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"We now report additional data from this trial on the possible role of daclizumab as an anti-inflammatory agent that affects asthma outcomes.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T98157","span":{"begin":0,"end":140},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T98157","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T120","span":{"begin":0,"end":140},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T120","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T168","span":{"begin":0,"end":140},"obj":"Sentence"}],"attributes":[{"subj":"T168","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T541","span":{"begin":124,"end":130},"obj":"Disease"}],"attributes":[{"id":"A541","pred":"mondo_id","subj":"T541","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"},{"subj":"T541","pred":"source","obj":"CORD-19-PD-MONDO"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T285","span":{"begin":124,"end":130},"obj":"Phenotype"}],"attributes":[{"id":"A285","pred":"hp_id","subj":"T285","obj":"http://purl.obolibrary.org/obo/HP_0002099"},{"subj":"T285","pred":"source","obj":"CORD-19-PD-HP"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ecbb","default":true},{"id":"Epistemic_Statements","color":"#eca193"},{"id":"CORD-19_Custom_license_subset","color":"#939eec"},{"id":"CORD-19-PD-MONDO","color":"#b8ec93"},{"id":"CORD-19-PD-HP","color":"#ec93d2"}]}]}}